NPI: 1669575908 · ELLINGTON, MO 63638 · Federally Qualified Health Center (FQHC) · NPI assigned 09/05/2006
Authorized official WHITE, KAREN controls 20+ related entities in our dataset. Read more
| Authorized Official | WHITE, KAREN (CEO) |
| Parent Organization | BIG SPRINGS MEDICAL ASSOCIATION |
| NPI Enumeration Date | 09/05/2006 |
Other providers sharing the same authorized official: WHITE, KAREN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,504 | $115K |
| 2019 | 4,579 | $230K |
| 2020 | 4,489 | $127K |
| 2021 | 5,763 | $111K |
| 2022 | 4,815 | $98K |
| 2023 | 8,198 | $208K |
| 2024 | 4,353 | $153K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6,592 | 5,887 | $412K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,891 | 1,704 | $165K |
| 80053 | Comprehensive metabolic panel | 5,302 | 5,064 | $100K |
| 80061 | Lipid panel | 2,878 | 2,764 | $87K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,826 | 2,742 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4,811 | 4,559 | $57K |
| 84439 | 2,142 | 2,097 | $44K | |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 1,442 | 1,215 | $32K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 645 | 626 | $21K |
| 83036 | Hemoglobin; glycosylated (A1C) | 865 | 837 | $20K |
| 82607 | 688 | 673 | $9K | |
| 82746 | 371 | 366 | $5K | |
| 87428 | 133 | 130 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 292 | 284 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 74 | 74 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 30 | 29 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 17 | 17 | $1K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 15 | 15 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 63 | 61 | $965.40 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 26 | 25 | $779.01 |
| 83735 | 125 | 121 | $722.06 | |
| 86703 | 46 | 46 | $589.20 | |
| 99406 | 38 | 37 | $443.20 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 14 | 14 | $387.27 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 16 | 16 | $328.44 |
| 80305 | 15 | 13 | $136.90 | |
| 96127 | 82 | 72 | $96.86 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 244 | 204 | $65.02 |
| 81001 | 17 | 16 | $41.47 | |
| 36415 | Collection of venous blood by venipuncture | 752 | 683 | $40.51 |
| 3008F | 764 | 684 | $0.00 | |
| 3074F | 253 | 218 | $0.00 | |
| 1220F | 405 | 362 | $0.00 | |
| 3079F | 29 | 25 | $0.00 | |
| 1125F | 62 | 53 | $0.00 | |
| 4010F | 14 | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 28 | 26 | $0.00 |
| 3078F | 127 | 112 | $0.00 | |
| 3725F | 274 | 247 | $0.00 | |
| 1160F | 622 | 548 | $0.00 | |
| 1159F | 656 | 574 | $0.00 | |
| 0521F | 15 | 14 | $0.00 |